Previous close | 28.26 |
Open | 28.26 |
Bid | 31.50 |
Ask | 34.20 |
Strike | 35.00 |
Expiry date | 2025-01-17 |
Day's range | 28.26 - 28.26 |
Contract range | N/A |
Volume | |
Open interest | 16 |
Boston Scientific made a bullish move Wednesday morning, topping two buy points on a solid first-quarter report.
Boston Scientific Corporation (NYSE:BSX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter earnings and issued guidance. The company generated first-quarter revenues of $3.86 billion, beating the consensus estimate of $3.69 billion. Sales soared 13.8% year-over-year on a reported basis, 15% on an operational basis, and 13.1% on an organic basis, beating the management guidance of approximately 7.5%-9.5% on a reported basis and approximately 7%-9
Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.